Clinical Trials
"Intralesional Cytokine Therapy in Cancer: A Phase I and II Study of Alpha Interferon and GM-CSF Infusion in Mesothelioma."
Published in Cancer Weekly, July 31st, 1995
According to an abstract submitted by the authors to the 1995 International Conference of the American Thoracic Society, held May 20-24, 1995, in Seattle, Washington, "Aim: To assess the effectiveness and toxicity of intralesional cytokine infusion in mesothelioma. Background: Systemic cytokine therapy in cancer has major side effects and we reasoned that the local infusion of cytokines could induce a local immunological response with minimal systemic toxicities and potentially strong systemic anti-cancer reactivity. Method: An intralesional epidural catheter was inserted and infused, using a portable pump, with recombinant human alpha 2b interferon (Intron,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1995-07-31)
More Articles from Cancer Weekly
- Editorial
Test Blood for HHV-6 - Antisense Technology
Oligodeoxynucleotides To Purge Bone Marrow in CML - Combination Therapies
Paclitaxel/Radiotherapy Sensitization: Will it Work for CNS Cancers? - Combination Therapies
Phase III Trial of Concomitant G-CSF with Chemoradiotherapy in Adult ALL - Conference Coverage
Piperacillin/Tazobactam Active Against Infections - Diagnostics
Test Developed to Facilitate Early Diagnosis of Lung Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
